Show simple item record

dc.contributor.authorGiussani, Dino A
dc.date.accessioned2022-01-06T11:51:41Z
dc.date.available2022-01-06T11:51:41Z
dc.date.issued2021-10-26
dc.identifier.issn0009-7322
dc.identifier.otherPMC8542082
dc.identifier.other34694887
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/332172
dc.description.abstractHeart disease remains one of the greatest killers. In addition to genetics and traditional lifestyle risk factors, we now understand that adverse conditions during pregnancy can also increase susceptibility to cardiovascular disease in the offspring. Therefore, the mechanisms by which this occurs and possible preventative therapies are of significant contemporary interest to the cardiovascular community. A common suboptimal pregnancy condition is a sustained reduction in fetal oxygenation. Chronic fetal hypoxia results from any pregnancy with increased placental vascular resistance, such as in preeclampsia, placental infection, or maternal obesity. Chronic fetal hypoxia may also arise during pregnancy at high altitude or because of maternal respiratory disease. This article reviews the short- and long-term effects of hypoxia on the fetal cardiovascular system, and the importance of chronic fetal hypoxia in triggering a developmental origin of future heart disease in the adult progeny. The work summarizes evidence derived from human studies as well as from rodent, avian, and ovine models. There is a focus on the discovery of the molecular link between prenatal hypoxia, oxidative stress, and increased cardiovascular risk in adult offspring. Discussion of mitochondria-targeted antioxidant therapy offers potential targets for clinical intervention in human pregnancy complicated by chronic fetal hypoxia.
dc.description.sponsorshipThe work is supported by The British Heart Foundation (RG/17/8/32924) and the Medical Research Council UK (MR/V03362X/1).
dc.languageeng
dc.publisherOvid Technologies (Wolters Kluwer Health)
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceessn: 1524-4539
dc.sourcenlmid: 0147763
dc.subjectfetus
dc.subjecthypoxia
dc.subjectmitochondria
dc.subjectoxidative stress
dc.subjectAnimals
dc.subjectCell Hypoxia
dc.subjectFemale
dc.subjectHeart Diseases
dc.subjectHumans
dc.subjectMale
dc.subjectOxidative Stress
dc.titleBreath of Life: Heart Disease Link to Developmental Hypoxia.
dc.typeArticle
dc.date.updated2022-01-06T11:51:40Z
prism.endingPage1443
prism.issueIdentifier17
prism.publicationNameCirculation
prism.startingPage1429
prism.volume144
dc.identifier.doi10.17863/CAM.79618
dcterms.dateAccepted2021-08-26
rioxxterms.versionofrecord10.1161/CIRCULATIONAHA.121.054689
rioxxterms.versionVoR
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0/
dc.contributor.orcidGiussani, Dino A [0000-0002-1308-1204]
dc.identifier.eissn1524-4539
pubs.funder-project-idBritish Heart Foundation (None)
pubs.funder-project-idMRC (unknown)
pubs.funder-project-idBritish Heart Foundation (None)
pubs.funder-project-idBritish Heart Foundation (RG/17/8/32924)
pubs.funder-project-idBritish Heart Foundation (via University of Manchester) (R122324)
cam.issuedOnline2021-10-25


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International